Steve Kaye
Overview
Explore the profile of Steve Kaye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1270
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mora-Peris B, Watson V, Vera J, Weston R, Waldman A, Kaye S, et al.
J Antimicrob Chemother
. 2014 Feb;
69(6):1642-7.
PMID: 24521854
Objectives: Pharmacokinetic parameters following modifications to antiretroviral therapy and sanctuary site exposure are often unknown for recently licensed antiretrovirals. We assessed plasma, CSF and seminal plasma (SP) exposure of rilpivirine...
12.
Tu E, Swenson L, Land S, Pett S, Emery S, Marks K, et al.
J Clin Microbiol
. 2013 Nov;
51(12):4287.
PMID: 24243995
No abstract available.
13.
Tu E, Swenson L, Land S, Pett S, Emery S, Marks K, et al.
J Clin Microbiol
. 2013 Apr;
51(7):2063-71.
PMID: 23596247
The Maraviroc Switch collaborative study (MARCH) is a study in aviremic patients on stable antiretroviral therapy and utilizes population-based sequencing of proviral DNA to determine HIV tropism and susceptibility to...
14.
Gall A, Kaye S, Hue S, Bonsall D, Rance R, Baillie G, et al.
Retrovirology
. 2013 Jan;
10:8.
PMID: 23331949
Background: Dynamic changes in Human Immunodeficiency Virus 1 (HIV-1) sequence diversity and divergence are associated with immune control during primary infection and progression to AIDS. Consensus sequencing or single genome...
15.
Fidler S, Porter K, Ewings F, Frater J, Ramjee G, Cooper D, et al.
N Engl J Med
. 2013 Jan;
368(3):207-17.
PMID: 23323897
Background: Short-course antiretroviral therapy (ART) in primary human immunodeficiency virus (HIV) infection may delay disease progression but has not been adequately evaluated. Methods: We randomly assigned adults with primary HIV...
16.
Singh S, Kaye S, Francis N, Peston D, Gore M, McClure M, et al.
Pigment Cell Melanoma Res
. 2013 Jan;
26(3):426-8.
PMID: 23311654
No abstract available.
17.
Vera J, Garvey L, Allsop J, Kaye S, McClure M, Back D, et al.
HIV Clin Trials
. 2012 Aug;
13(4):222-7.
PMID: 22849963
Background: Cerebrospinal (CSF) fluid biomarkers may be a useful tool for assessing the cerebral effects of antiretroviral therapy. Objective: The aim of the study was to investigate the relationship between...
18.
Hamlyn E, Hickling S, Porter K, Frater J, Phillips R, Robinson M, et al.
AIDS
. 2012 Feb;
26(7):887-90.
PMID: 22313951
CXCR4-tropic (X4) HIV-1 variants are associated with faster disease progression compared with CCR5-tropic variants; however, the mechanism for this is unclear. We measured T-cell activation in 120 individuals with primary...
19.
Robinson M, Tuke P, Erlwein O, Tettmar K, Kaye S, Naresh K, et al.
Adv Virol
. 2012 Feb;
2011:782353.
PMID: 22312352
Xenotropic murine leukaemia virus-related virus (XMRV) is a recently described retrovirus which has been claimed to infect humans and cause associated pathology. Initially identified in the US in patients with...
20.
van Tienen C, McConkey S, I de Silva T, Cotten M, Kaye S, Sarge-Njie R, et al.
AIDS Res Hum Retroviruses
. 2011 Nov;
28(6):584-90.
PMID: 22066980
The relative importance of routes of transmission of human T cell lymphotropic virus type 1 (HTLV-1) in Guinea-Bissau is largely unknown; vertical transmission is thought to be important, but there...